Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00137878 | TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer | completed | Phase 2 | — | GenVecINDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00003714 | Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 22, 2012 | clinicaltrials |
| NCT00068575 |
| Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer |
| completed |
| Phase 2 |
| 29 |
| M.D. Anderson Cancer CenterOTHER |
| 1 |
| Feb 15, 2012 |
| clinicaltrials |
| NCT01533324 | S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 32 | Second Military Medical UniversityOTHER | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00074009 | Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00257426 | Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer | completed | Phase 2 | 31 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00082862 | Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer | unknown | Phase 2 | 48 | The University of Texas Health Science Center, HoustonOTHER | 1 | Feb 13, 2012 | clinicaltrials |
| NCT00913198 | A Study of CP-4126 in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 21 | Clavis PharmaINDUSTRY | 2 | Feb 10, 2012 | clinicaltrials |
| NCT00952497 | A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer | completed | Phase 2 | 48 | ACT Biotech, IncINDUSTRY | 2 | Feb 8, 2012 | clinicaltrials |
| NCT00176774 | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma | completed | Phase 2 | 24 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01528059 | Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes | unknown | Phase 2 / Phase 3 | 110 | feng ZhengOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00609310 | Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia Recurrence | suspended | Phase 2 | 382 | Technische Universität DresdenOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT01525719 | Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma(CRAD001T) | unknown | Phase 2 | 40 | Ratchavithi HospitalOTHER_GOV | 0 | Feb 3, 2012 | clinicaltrials |
| NCT00313859 | Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC | completed | Phase 2 | 50 | Samsung Medical CenterOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT00966706 | Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer(PACT-9) | completed | Phase 2 | 105 | IRCCS San RaffaeleOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00967291 | Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer(PACT-11) | terminated | Phase 2 | 21 | IRCCS San RaffaeleOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00967603 | Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer(PACT-12) | completed | Phase 2 | 56 | IRCCS San RaffaeleOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00969033 | CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin | terminated | Phase 2 | 8 | Daiichi SankyoINDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00898287 | Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer(SAVIOR) | completed | Phase 1 / Phase 2 | 23 | Piramal Enterprises LimitedINDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00122291 | A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer | unknown | Phase 2 | 66 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00661167 | Phase II Study of ABI-007 for Gastric Cancer | completed | Phase 2 | 56 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 18, 2012 | clinicaltrials |
| NCT00690677 | Phase II Trial of LBH589 in Refractory Colorectal Cancer | completed | Phase 2 | 29 | Swedish Medical CenterOTHER | 1 | Jan 18, 2012 | clinicaltrials |
| NCT00891332 | Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer | completed | Phase 2 | 73 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 2 | Jan 18, 2012 | clinicaltrials |
| NCT00215995 | Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas | completed | Phase 2 | 21 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 2 | Jan 13, 2012 | clinicaltrials |
| NCT00960284 | Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer(PACT-7) | completed | Phase 2 / Phase 3 | 102 | IRCCS San RaffaeleOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT00084942 | Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder | completed | Phase 2 | — | Roswell Park Cancer InstituteOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT01486992 | mFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT01426646 | S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer | unknown | Phase 2 | 218 | Kyungpook National University HospitalOTHER | 1 | Jan 5, 2012 | clinicaltrials |
| NCT00297128 | Preoperative Chemoradiation With Capecitabine and Cetuximab | completed | Phase 2 | 31 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 30, 2011 | clinicaltrials |
| NCT00002935 | Photodynamic Therapy in Treating Patients With Early Esophageal Cancer | completed | Phase 2 | 30 | Roswell Park Cancer InstituteOTHER | 1 | Dec 23, 2011 | clinicaltrials |
| NCT01042743 | Laparoscopic Surgery Versus Robot Surgery for Right-side Colon Cancer: Short-term Outcome of a Randomised Clinical Trial | completed | Phase 2 | 80 | Kyungpook National University HospitalOTHER | 1 | Dec 20, 2011 | clinicaltrials |
| NCT01494363 | Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer | unknown | Phase 2 | 53 | Soon Chun Hyang UniversityOTHER | 1 | Dec 19, 2011 | clinicaltrials |
| NCT00422864 | A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer | completed | Phase 2 | 26 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Dec 15, 2011 | clinicaltrials |
| NCT00111904 | Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 43 | TheradexINDUSTRY | 1 | Dec 14, 2011 | clinicaltrials |
| NCT01491217 | A Study of Oraxol® in Gastric Cancer Patients | unknown | Phase 1 / Phase 2 | 53 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | Dec 13, 2011 | clinicaltrials |
| NCT01234051 | Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer | unknown | Phase 2 | 53 | Korean South West Oncology GroupNETWORK | 1 | Dec 12, 2011 | clinicaltrials |
| NCT01489332 | Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Dec 9, 2011 | clinicaltrials |
| NCT00006379 | Non-Ablative Allo HSCT For Hematologic Malignancies or SAA | completed | Phase 2 | 58 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 8, 2011 | clinicaltrials |
| NCT00659113 | S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery | unknown | Phase 2 | 32 | Yonsei UniversityOTHER | 1 | Dec 6, 2011 | clinicaltrials |
| NCT00786006 | Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer | completed | Phase 2 | 61 | Asan Medical CenterOTHER | 1 | Dec 6, 2011 | clinicaltrials |
| NCT01268384 | Neoadjuvant FDR GX in Locally Advanced Pancreatic Cancer | completed | Phase 2 | 43 | Asan Medical CenterOTHER | 1 | Dec 6, 2011 | clinicaltrials |
| NCT01175291 | FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer | withdrawn | Phase 2 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Dec 5, 2011 | clinicaltrials |
| NCT00673504 | First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 105 | Central European Society for Anticancer Drug ResearchOTHER | 2 | Dec 1, 2011 | clinicaltrials |
| NCT01155440 | Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine | completed | Phase 2 | 60 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT01477190 | Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program | completed | Phase 1 / Phase 2 | 40 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT00866944 | Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases(MT201-204) | completed | Phase 2 | 35 | Amgen Research (Munich) GmbHINDUSTRY | 2 | Nov 11, 2011 | clinicaltrials |
| NCT01349517 | Health-related Quality of Life of Patients With Esophageal Cancer After Surgery | unknown | Phase 2 | 400 | Fudan UniversityOTHER | 1 | Nov 11, 2011 | clinicaltrials |
| NCT00354978 | Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | completed | Phase 2 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT01070355 | Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases(EMT) | completed | Phase 2 | 88 | University of LeedsOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT00985556 | Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer | unknown | Phase 2 | 130 | Yonsei UniversityOTHER | 1 | Oct 20, 2011 | clinicaltrials |
Data updated 24 days agoSource updated Feb 23, 2012source: clinicaltrials